Skip to main content
Livermore
Livermore
ZHEN

Amalgamated Bank

SEC CIK
0000919192
Latest filing
Jul 23, 2026

RCKT holding history

Rocket Pharmaceuticals, Inc. in every 13F filed by Amalgamated Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RCKT overviewAll 13F holders of RCKTFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
19
Since Q1 2021
Holdings of RCKT by Amalgamated Bank, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−2,662−100.0%Sold outHolders
Q4 20252,662$9.00K<0.1%+5+0.2%AddedHolders
Q3 20252,657$9.00K<0.1%00.0%UnchangedHolders
Q2 20252,657$7.00K<0.1%00.0%UnchangedHolders
Q1 20252,657$18.0K<0.1%+517+24.2%AddedHolders
Q4 20242,140$27.0K<0.1%00.0%UnchangedHolders
Q3 20242,140$40.0K<0.1%00.0%UnchangedHolders
Q2 20242,140$46.0K<0.1%00.0%UnchangedHolders
Q1 20242,140$58.0K<0.1%−6,513−75.3%ReducedHolders
Q4 20238,653$259.0K<0.1%+440+5.4%AddedHolders
Q3 20238,213$168.0K<0.1%00.0%UnchangedHolders
Q2 20238,213$163.0K<0.1%+2,434+42.1%AddedHolders
Q1 20235,779$99.0K<0.1%−1,285−18.2%ReducedHolders
Q4 20227,064$138.0K<0.1%+1,503+27.0%AddedHolders
Q3 20225,561$89.0K<0.1%00.0%UnchangedHolders
Q2 20225,561$77.0K<0.1%−1,150−17.1%ReducedHolders
Q1 20226,711$106.0K<0.1%+6,711NewHolders
Q4 20210$00.0%−7,238−100.0%Sold outHolders
Q3 20217,238$216.0K<0.1%−264−3.5%ReducedHolders
Q2 20217,502$332.0K<0.1%+2,179+40.9%AddedHolders
Q1 20215,323$236.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.